New ACTA Agreement Sparks Debate Among Anti-Counterfeiting Professionals
The ACTA, a proposed agreement created for the purpose of establishing international standards regarding the enforcement of intellectual property rights, sparked many controversies about the parts relating to the online counterfeiting.
By: Pharma IQ
Discussions regarding this agreement started in 2007 with formal negotiations starting from June 2008 which are still ongoing and particularly hard to implement, as it requires voluntary help from several countries. The agreement looks set to be one of the major points of discussion at a forthcoming gathering of industry professionals in early 2011.
Counterfeits online sales as well as the fake webshops will be widely discussed at the Brand Protection and Anti-Counterfeiting Interactive Forum, taking place in Copenhagen, 12-13 April 2011. The Interactive Forum will enable the participants to network, benchmark and share their ideas with the industry peers during panel discussions and round table sessions.
The key topics will include:
-Overcoming the online challenges to brand protection and anti-counterfeiting:
-Preserving your original ideas and developing your brand: ensuring your brand development doesn’t fold under competition from counterfeiters and external traders during mergers and acquisitions and the early stages of development
-Protecting your brand through mergers and acquisitions:
-Solutions to tackle counterfeiting and illicit trade: Explore the options available to target brand infringements at the source and through online management
For more information please visit www.brandprotectionforum.com, call 44 (0) 2073689421 or email email@example.com
# # #
Pharma IQ, a division of IQPC, is an international online community focusing on providing pharmaceutical professionals with knowledge, information and articles. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical community
Through Pharma IQ, you will be able to access pharmaceutical information resources such as presentations and podcasts, as well as events such as webinars, seminars and conferences.